Clinical Trials Browser

Lymphoma, B-Cell, Marginal Zone

NCT04214626 2025-11-19

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Phase 2 Completed

60 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Phase 2 Suspended

59 enrolled

Lymphoid

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Phase 2 Active not recruiting

200 enrolled

Breast

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

NCT05963347 2023-09-01

Go-CHOP as the Frontline Therapy for PTCL

Phase 2 Recruiting

45 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03166397 2023-01-26

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Phase 2 Unknown

30 enrolled

Dermatologic

Melanoma

NCT03648697 2020-08-11

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

Phase 2 Unknown

20 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03601624 2018-11-14

MM-POM-2018

Phase 2 Unknown

18 enrolled

Plasma cell

Multiple Myeloma, Recurrence, Disease Progression

NCT03654703 2018-08-31

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Phase 2 Unknown

100 enrolled

Hematopoietic System--Cancer

NCT03497702 2018-04-13

NeoChAI

Phase 2 Unknown

114 enrolled

Breast

Breast Neoplasms

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Phase 2 Completed

58 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Clinical Trials

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Go-CHOP as the Frontline Therapy for PTCL

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

MM-POM-2018

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

NeoChAI

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer